Literature DB >> 16239563

Dra/AfaE adhesin of uropathogenic Dr/Afa+ Escherichia coli mediates mortality in pregnant rats.

K Wroblewska-Seniuk1, R Selvarangan, A Hart, R Pladzyk, P Goluszko, A Jafari, L du Merle, S Nowicki, C Yallampalli, C Le Bouguénec, B Nowicki.   

Abstract

Escherichia coli bearing adhesins of the Dr/Afa family frequently causes urogenital infections during pregnancy in humans and has been associated with mortality in pregnant rats. Two components of the adhesin, Dra/AfaE and Dra/AfaD, considered virulence factors, are responsible for bacterial binding and internalization. We hypothesize that gestational mortality caused by Dr/Afa+ E. coli is mediated by one of these two proteins, Dra/AfaE or Dra/AfaD. In this study, using afaE and/or afaD mutants, we investigated the role of the afaE and afaD genes in the mortality of pregnant rats from intrauterine infection. Sprague-Dawley rats, on the 17th day of pregnancy, were infected with the E. coli afaE+ afaD and afaE afaD+ mutants. The clinical E. coli strain (afaE+ afaD+) and the afaE afaD double mutant were used as positive and negative controls, respectively. The mortality rate was evaluated 24 h after infection. The highest maternal mortality was observed in the group infected with the afaE+ afaD+ strain, followed by the group infected with the afaE+ afaD strain. The mortality was dose dependent. The afaE afaD double mutant did not cause maternal mortality, even with the highest infection dose. The in vivo studies corresponded with the invasion assay, where the afaE+ strains were the most invasive (afaE+ afaD strain > afaE+ afaD+ strain), while the afaE mutant strains (afaE afaD+ and afaE afaD strains) seemed to be noninvasive. This study shows for the first time that the afaE gene coding for the AfaE subunit of Dr/Afa adhesin is involved in the lethal outcome of gestational infection in rats. This lethal effect associated with AfaE correlates with the invasiveness of afaE+ E. coli strains in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239563      PMCID: PMC1273835          DOI: 10.1128/IAI.73.11.7597-7601.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion.

Authors:  Margaret Das; Audrey Hart-Van Tassell; Petri T Urvil; Susan Lea; David Pettigrew; K L Anderson; Alfred Samet; Jozef Kur; Steve Matthews; Stella Nowicki; Vsevolod Popov; Pawel Goluszko; Bogdan J Nowicki
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Dr operon-associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis.

Authors:  P Goluszko; D Niesel; B Nowicki; R Selvarangan; S Nowicki; A Hart; E Pawelczyk; M Das; P Urvil; R Hasan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

3.  Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin.

Authors:  A Hart; B J Nowicki; B Reisner; E Pawelczyk; P Goluszko; P Urvil; G Anderson; S Nowicki
Journal:  J Infect Dis       Date:  2001-04-06       Impact factor: 5.226

4.  Differential expression of uterine NO in pregnant and nonpregnant rats with intrauterine bacterial infection.

Authors:  L Fang; B Nowicki; C Yallampalli
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-05       Impact factor: 3.619

5.  Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection.

Authors:  B Nowicki; L Truong; J Moulds; R Hull
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

6.  Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli.

Authors:  R Selvarangan; P Goluszko; V Popov; J Singhal; T Pham; D M Lublin; S Nowicki; B Nowicki
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Recognition of the cellular beta1-chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa-expressing pathogenic Escherichia coli strains.

Authors:  Laure Plançon; Laurence Du Merle; Sandrine Le Friec; Pierre Gounon; Mabel Jouve; Julie Guignot; Alain Servin; Chantal Le Bouguénec
Journal:  Cell Microbiol       Date:  2003-10       Impact factor: 3.715

Review 8.  Urinary tract infections during pregnancy.

Authors:  Jennifer Le; Gerald G Briggs; Anna McKeown; Gerardo Bustillo
Journal:  Ann Pharmacother       Date:  2004-08-31       Impact factor: 3.154

9.  Distribution and degree of heterogeneity of the afimbrial-adhesin-encoding operon (afa) among uropathogenic Escherichia coli isolates.

Authors:  A Labigne-Roussel; S Falkow
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

10.  An atomic resolution model for assembly, architecture, and function of the Dr adhesins.

Authors:  Kirstine L Anderson; Jason Billington; David Pettigrew; Ernesto Cota; Peter Simpson; Pietro Roversi; Ho An Chen; Petri Urvil; Laurence du Merle; Paul N Barlow; M Edward Medof; Richard A G Smith; Bogdan Nowicki; Chantal Le Bouguénec; Susan M Lea; Stephen Matthews
Journal:  Mol Cell       Date:  2004-08-27       Impact factor: 17.970

View more
  4 in total

1.  Maternal/fetal mortality and fetal growth restriction: role of nitric oxide and virulence factors in intrauterine infection in rats.

Authors:  Katarzyna Wroblewska-Seniuk; Stella Nowicki; Chantal Le Bouguénec; Bogdan Nowicki; Chandra Yallampalli
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

Review 2.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Differential Afa/Dr Fimbriae Expression in the Multidrug-Resistant Escherichia coli ST131 Clone.

Authors:  Laura Alvarez-Fraga; Minh-Duy Phan; Kelvin G K Goh; Nguyen Thi Khanh Nhu; Steven J Hancock; Luke P Allsopp; Kate M Peters; Brian M Forde; Leah W Roberts; Matthew J Sullivan; Makrina Totsika; Scott A Beatson; Glen C Ulett; Mark A Schembri
Journal:  mBio       Date:  2022-01-18       Impact factor: 7.867

4.  Pathogenomics and clinical recurrence influence biofilm capacity of Escherichia coli isolated from canine urinary tract infections.

Authors:  Gregory A Ballash; Dixie F Mollenkopf; Dubraska Diaz-Campos; Joany C van Balen; Rachel E Cianciolo; Thomas E Wittum
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.